Drug reference
Dicycloverine hydrochloride
Antimuscarinic · Gastrointestinal Antispasmodic
Also known as Dicyclomine hydrochloride
AntimuscarinicGastrointestinal Antispasmodic
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
Not known to be harmful; manufacturer advises use only if essential.
FDA category + note
Mechanism
Dicycloverine hydrochloride exerts an antimuscarinic action, which is less marked than atropine sulfate. It may also possess a direct action on smooth muscle. These actions collectively lead to reduced intestinal motility.
Indications
Symptomatic relief of gastro-intestinal disorders characterised by smooth muscle spasmIrritable bowel syndrome
Dosing
- Adult
- 10–20 mg 3 times a day
- Pediatric
- Child 6–23 months: 5–10 mg 3–4 times a day, dose to be taken 15 minutes before feeds; Child 2–11 years: 10 mg 3 times a day; Child 12–17 years: 10–20 mg 3 times a day
- Max dose
- 60 mg daily
Contraindications
- Paralytic ileus
Side effects
Common
Appetite decreasedfatiguethirst
Serious
- Apnoea (reported in infant exposed via breast milk)
Pregnancy & lactation
Pregnancy
Not known to be harmful; manufacturer advises use only if essential.
Lactation
Avoid—present in milk; apnoea reported in infant.
Related guidelines
Irritable bowel syndrome
ISG · Gastroenterology · 2023
Inflammatory bowel disease
OTHER · Gastroenterology · 2015
Empirical antimicrobial use in common syndromes
ICMR · Infectious Diseases · 2019
Preventive care in inflammatory bowel disease
ACG · Gastroenterology · 2025
Gastro-oesophageal reflux disease
ISG · Gastroenterology · 2022
Other Antimuscarinic drugs
Ask House about Dicycloverine hydrochloride
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: BNF·Verified: 2026-05-10 · House clinical team